糖尿病患者行白内障超声乳化联合人工晶体植入术的临床效果
师雅益
（蒲城县中医医院，陕西 渭南，715500）
浏览次数：69次 下载次数：362次
摘要：
目的 观察糖尿病患者行白内障超声乳化联合人工晶体植入术治疗的临床效果。方法 选择2014年1月至2016年10月我院收治的150例（210眼）糖尿病白内障患者为观察组，并选取同时期的150 例（206 眼）非糖尿病白内障患者为对照组， 均进行白内障超声乳化联合人工晶体植入术进行治疗，对两组患者的临床治疗效果进行分析。结果 两组患者术后视力均有明显提高，观察组患者术后矫正视力>0.5 者为173眼（82.38%)，对照组为174 眼（84.47%），组间比较，差异无统计学意义（x2= 0.3268，P>0.05）。术后观察组前房炎症反应、角膜水肿、后弹力层皱褶均较对照组严重，给予妥布霉素地塞米松点眼后7～10 d消退。两组患者均未见视网膜脱离及角膜内皮失代偿等严重并发症，观察组患者的术中瞳孔缩小发生率高于对照组（P< 0.01），而两组的后囊膜破裂发生率无显著差异（P>0.05）。结论 随着临床显微手术水平的提高，糖尿病不再是白内障手术禁忌，在控制血糖稳定的前提下行白内障超声乳化联合人工晶体植入术，可显著提高糖尿病白内障患者的视力水平，且不良反应可控，具有较好的临床应用价值。
关键词：糖尿病；白内障；超声乳化；人工晶体植入术
中图分类号：R779.6文献标志码：A文章编号：2096-1413(2017)21-0046-02
Clinical effect of cataract phacoemulsification combined with iol implantation in patients with diabetic
SHI Ya-yi
(Pucheng Traditional Chinese Medical Hospital, Weinan 715500, China)
ABSTRACT: Objective To explore the clinical effect of cataract phacoemulsification combined with iol implantation in patients with diabetic. Methods From January 2014 to October 2016, 150 cases (210 eyes) of diabetic cataract patients were selected as the observation group, another 150 cases (206 eyes) of non-diabetic cataract patients in the same period were selected as the control group. Cataract phacoemulsification combined with iol implantation was conducted in the two groups, and the clinical effects were compared in the two groups. Results The postoperative visual acuity were significantly improved in the two groups, the postoperative corrected visual acuity > 0.5 in the observation group were 173 eyes (82.38%) and 174 eyes (84.47%) in the control groups, the difference was not significant ( x2=0.3268, P>0.05). The anterior chamber inflammation, corneal edema and posterior elastic layer wrinkles in observation group were more severe than the control group, and subsided after 7 to 10 d tobramycin dexamethasone exposure. There were no serious complications such as retinal detachment and corneal endothelial decompensation occurred in the two groups. The incidence of intraoperative miosis in the observation group was higher than that in the control group (P<0.01), but there was no significant difference in the incidence of posterior capsule rupture between the two groups (P>0.05). Conclusion With the development of the level of operating treatment, diabetes is not a taboo for cataract surgery anymore. Taking phacoemulsification combined with iol implantation on the basis of blood glucose remains constant can observably improve the vision of cataract patients, with fewer controllable complications and better clinical application value.
KEYWORDS: diabetes; cataract; phacoemulsification; iol implantation
参考文献：
[1] 李晓玲,陈云辉.糖尿病患者白内障超声乳化吸除联合人工晶体植入术的护理[J].护理实践与研究,2011,8(16):58-59.
[2] 徐晋,俞江,胡然,等.糖尿病患者白内障超声乳化吸除联合折叠式人工晶体植入术的临床疗效分析[J].齐齐哈尔医学院学报,2011,32(13):2082-2083.
[3] PARK DH,SHIN JP,KIM SY.Combined 23-gauge microincisonal vitrectomy surgery and phacoemulsification with AcrySof toric intraocular lens implantation: a comparative study[J].Eye,2011,25(10):1327-1332.
[4] LEE SJ,LEE CK,KIM WS.Long -term therapeutic efficacy of phacoemulsification with intraocular lens implantation in patients with phacomorphic glaucoma[J].J Cataract Refract Surg,2010,36(5):783-789.
[5] 张奇,李娜,马雅玲.糖尿病患者白内障超声乳化联合人工晶体植入术的临床观察[J].宁夏医学杂志,2011,33(6):537-539.